Rationale and Objectives: Fractional flow reserve (FFR) is an established technique for detecting lesion-specific ischemia but is invasive. Our objective was to investigate the effects of combined assessment of coronary CT angiography (CCTA) imaging features and CT-FFR on detecting lesion-specific ischemia by comparing with invasive FFR. Materials and Methods: Forty-seven patients who had 60 coronary vessels with 30%À90% stenosis were included. Six anatomic CCTA descriptors (Agatston score, stenosis severity, mean plaque CT attenuation value, noncalcified and calcified plaque volumes, remodeling index) and a functional descriptor (CT-FFR) were measured. Random forest was used to identify which descriptors were useful to identify ischemia-related lesion. Receiver-operating characteristic (ROC) curves were calculated for 2 models: i.e. Model-1 for anatomical CT descriptors and Model-2 for anatomical CT descriptors plus CT-FFR. Results: Stenosis severity (40.8 § 15.7% vs 57.6 § 14.1%), noncalcified plaque volume (190 § 100 vs 254.8 § 133.3), and remodeling index (1.04 § 0.12 vs 1.11 § 0.13) were significantly higher in ischemia-related lesions than nonischemia-related lesions. CT-FFR was 0.84 § 0.14 and 0.71 § 0.14, respectively, for ischemia-related and nonischemia-related lesions, and the difference was significant. The area under the ROC curve was 0.738 and 0.835 in Model-1 and Model-2, respectively. Reclassification of ischemic lesion risk was significantly improved after adding CT-FFR: net reclassification improvement was 0.297 and integrated discrimination improvement was 0.254. Conclusion: Combined assessment of anatomical CCTA features and functional CT-FFR was helpful for detecting lesion-specific ischemia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.